Accomplished synthetic biologist and team leader leveraging 8+ years of research experience across academia and industry. Demonstrated expertise in gene therapy, viral vector engineering, and innovative therapeutics development.Currently leading efforts to resolve manufacturing challenges constraining recombinant AAV-based therapies as a postdoctoral researcher at Harvard Medical School’s Grousbeck Gene Therapy Center. Previously, completed PhD in Synthetic Biology from ETH Zurich, having designed novel therapeutic gene circuits to selectively target cancerous cells.Skilled scientific leader, as shown by roles in organizing academic events, supervising students, and reviewing manuscripts for top journals.Passionate about translating research innovations into new medicines. Leveraging cross-disciplinary scientific training, technical knowledge in cloning and gene editing, and collaboration skills to drive advancements in gene and cell therapy.Seeking industry roles in R&D leadership, gene therapy process sciences, or technical consulting where scientific expertise and strategic leadership abilities can be applied to elevate patient health through development of transformative genomic medicines.